ConductScience.org, home

Paper32102432

N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.

Kaczor AA and 5 others. Biomolecules, 2020. Cited by 12 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic. Papers, record 32102432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32102432

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.
PubMed
Journal
Biomolecules
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2024-03-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaczor AAAgnieszka Ahttps://orcid.org/0000-0001-8679-9623
2Targowska-Duda KMKatarzyna M
3Silva AGAndrea Ghttps://orcid.org/0000-0003-2034-1796
4Kondej MMagda
5Biała GGrażyna
6Castro MMariánhttps://orcid.org/0000-0002-4732-1966

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PiperidinesMajor topic
Animals
Antipsychotic Agents
Drug Design
Humans
Ligands
Models, Molecular
Receptors, G-Protein-Coupled
Schizophrenia
Structure-Activity Relationship

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2017/27/B/NZ7/01767Narodowe Centrum NaukiInternationalPubMed
SAF2014-57138-C2-1-RMinisterio de Economía, Industria y Competitividad, Gobierno de EspañaInternationalPubMed

Source PubMed

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117,548,746Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.Arch Gen Psychiatry2007https://conductscience.org/library/papers/17548746PubMed
224,631,727Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles.Eur J Med Chem2014https://conductscience.org/library/papers/24631727PubMed
324,677,189The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.CNS Drugs2014https://conductscience.org/library/papers/24677189PubMed
424,794,100Role of atypical antipsychotics in the treatment of generalized anxiety disorder.CNS Drugs2014https://conductscience.org/library/papers/24794100PubMed
518,465,762Multi-receptor binding profile of clozapine and olanzapine: a structural study based on the new beta2 adrenergic receptor template.ChemMedChem2008https://conductscience.org/library/papers/18465762PubMed
619,922,537Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.Br J Pharmacol2010https://conductscience.org/library/papers/19922537PubMed
725,806,997Multi-Step Protocol for Automatic Evaluation of Docking Results Based on Machine Learning Methods--A Case Study of Serotonin Receptors 5-HT(6) and 5-HT(7).J Chem Inf Model2015https://conductscience.org/library/papers/25806997PubMed
830,723,326Structures of the 5-HT2A receptor in complex with the antipsychotics risperidone and zotepine.Nat Struct Mol Biol2019https://conductscience.org/library/papers/30723326PubMed
931,703,784Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.Nurs Clin North Am2019https://conductscience.org/library/papers/31703784PubMed
109,619,146Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.Am J Psychiatry1998https://conductscience.org/library/papers/9619146PubMed
1128,889,207Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.Psychopharmacology (Berl)2017https://conductscience.org/library/papers/28889207PubMed
1219,617,654Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.J Physiol Pharmacol2009https://conductscience.org/library/papers/19617654PubMed
1310,807,680[(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors.Br J Pharmacol2000https://conductscience.org/library/papers/10807680PubMed
1427,322,406Comparative Protein Structure Modeling Using MODELLER.Curr Protoc Bioinformatics2016https://conductscience.org/library/papers/27322406PubMed
1528,400,155Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients.Eur Neuropsychopharmacol2017https://conductscience.org/library/papers/28400155PubMed
1628,745,550Improvising 5-HT7R homology model for design of high affinity ligands: model validation with docking, embrace minimization, MM-GBSA, and molecular dynamic simulations.J Biomol Struct Dyn2018https://conductscience.org/library/papers/28745550PubMed
1724,245,803New strategy for receptor-based pharmacophore query construction: a case study for 5-HT₇ receptor ligands.J Chem Inf Model2013https://conductscience.org/library/papers/24245803PubMed
1821,449,915Animal models of schizophrenia.Br J Pharmacol2011https://conductscience.org/library/papers/21449915PubMed
1922,893,011Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis.Ann Intern Med2012https://conductscience.org/library/papers/22893011PubMed
2023,999,469Effects of imperatorin on nicotine-induced anxiety- and memory-related responses and oxidative stress in mice.Physiol Behav2013https://conductscience.org/library/papers/23999469PubMed

See all 58 references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
39,376,479Recent advances in the synthesis of antidepressant derivatives: pharmacologic insights for mood disorders.3 Biotech2024https://conductscience.org/library/papers/39376479PubMed
37,184,096Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds-synthesis, biological activity, and structural evaluation.J Enzyme Inhib Med Chem2023https://conductscience.org/library/papers/37184096PubMed
36,615,578Synthesis, Structural and Behavioral Studies of Indole Derivatives D2AAK5, D2AAK6 and D2AAK7 as Serotonin 5-HT1A and 5-HT2A Receptor Ligands.Molecules2023https://conductscience.org/library/papers/36615578PubMed
36,476,619Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes.Sci Rep2022https://conductscience.org/library/papers/36476619PubMed
36,235,029Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus.Molecules2022https://conductscience.org/library/papers/36235029PubMed
34,194,566Actualities in immunological markers and electrochemical sensors for determination of dopamine and its metabolites in psychotic disorders (Review).Exp Ther Med2021https://conductscience.org/library/papers/34194566PubMed
32,652,312Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors.Drug Discov Today2020https://conductscience.org/library/papers/32652312PubMed

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HTR1A3,350PubTator's text mininghttps://conductscience.org/library/genes/3350NCBI Gene
HTR2A3,356PubTator's text mininghttps://conductscience.org/library/genes/3356NCBI Gene
HTR73,363PubTator's text mininghttps://conductscience.org/library/genes/3363NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32102432

GET https://conductscience.org/api/papers/v1/32102432/references?page=2